Skip to content

Study to find how homeopathic medicines help with nearsightedness (myopia)

Clinical study to evaluate the effectiveness of Physostigma venenosum 6c, Eserinum 6c and homoeopathic ‘constitutional remedies’ in developmental myopia - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064704
Enrollment
160
Registered
2024-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: Medicinal Group: 1.Physostigma 6C Group 2.Eserinum 6C Group 3.Homoeopathic Constitutional remedies Control Intervention1: Control group: Corrective spectacles.?

Sponsors

Vinayaka Missions Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants with varying degrees of myopia more than? -0.5D, with a specified age range 19 years to 45 years, will be included.? Moderate to High myopic children in ages ranging 7 to 11 years.? Moderate to low myopic children in ages ranging 7 to 11 with parental myopic history are included.? Bilateral or unilateral myopia (ICD11-9D00.0) associated with astigmatism, blurred vision, headache or eye strain are included.?

Exclusion criteria

Exclusion criteria: Anyone who is already under homoeopathic treatment.? Anyone who has undergone recent myopia-related treatment (use of ophthalmic solutions or surgical measures).? Congenital conditions (ICD11-LD27.Y, LA14.0Y, LA12.Y, 9B70)? Degenerative myopia (ICD11-9B76)?

Design outcomes

Primary

MeasureTime frame
All three medicines were effective in slowing down myopia progression, also reduction in diopters is noted along with reduction in the intensity of the associated symptoms.? ? Progression of myopia was better in the constitutional medicine group.? ? No remission of myopia or associated symptoms post treatment with constitutional medicine.?Timepoint: Ophthalmic assessment done once in three months until one year and followed up for six more months

Secondary

MeasureTime frame
Establishing anti myopic activity of specific drugsTimepoint: Every three months after the beginning of treatment protocol ophthalmic assessment is done for one year, i.e., four assessments for each patient

Countries

India

Contacts

Public ContactDr E Rathnasabapathi

Vinayaka mission’s homoeopathic medical college and hospital, VMRF-DU, Salem

rozee1234@gmail.com9894431131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026